BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie D, Sham JS, Zeng WF, Lin HL, Bi J, Che LH, Hu L, Zeng YX, Guan XY. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum Pathol. 2005;36:777-783. [PMID: 16084947 DOI: 10.1016/j.humpath.2005.05.007] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Zhang J, Jiang L, Wang F, Liu L, Liao Y, Jin X, Chen W, Chen X, Guo S, Zhou F, Zeng Y, Guan X, Liu Z, Xie D. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B. Oncogene 2016;35:6281-92. [DOI: 10.1038/onc.2016.165] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
2 Huang Y, Wei J, Fang Y, Chen Z, Cen J, Feng Z, Lu J, Liang Y, Luo J, Chen W. Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma. Cancer Manag Res 2018;10:6997-7011. [PMID: 30588104 DOI: 10.2147/CMAR.S185392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
3 Xu Y, Chen Q, Li W, Su X, Chen T, Liu Y, Zhao Y, Yu C. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness. Oncogene 2010;29:3386-97. [DOI: 10.1038/onc.2010.90] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
4 Theodosi A, Ouzounis S, Kostopoulos S, Glotsos D, Kalatzis I, Tzelepi V, Ravazoula P, Asvestas P, Cavouras D, Sakellaropoulos G. Design of a hybrid deep learning system for discriminating between low- and high-grade colorectal cancer lesions, using microscopy images of IHC stained for AIB1 expression biopsy material. Machine Vision and Applications 2021;32. [DOI: 10.1007/s00138-021-01184-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ji H, Kumm J, Zhang M, Farnam K, Salari K, Faham M, Ford JM, Davis RW. Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma. Cancer Res. 2006;66:7910-7919. [PMID: 16912164 DOI: 10.1158/0008-5472.can-06-0595] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
6 Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation. Mol Oncol 2018;12:391-405. [PMID: 29360267 DOI: 10.1002/1878-0261.12173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
7 Chen Y, Xie D, Yin Li W, Man Cheung C, Yao H, Chan CY, Chan CY, Xu FP, Liu YH, Sung JJ, Kung HF. RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Cancer Lett 2010;297:109-16. [PMID: 20684863 DOI: 10.1016/j.canlet.2010.05.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
8 Grivas PD, Tzelepi V, Sotiropoulou-Bonikou G, Kefalopoulou Z, Papavassiliou AG, Kalofonos H. Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? Int J Colorectal Dis. 2009;24:613-622. [PMID: 19198856 DOI: 10.1007/s00384-009-0647-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
9 Luo JH, Hua WF, Rao HL, Liao YJ, Kung HF, Zeng YX, Guan XY, Chen W, Xie D. Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder. Cancer Sci. 2009;100:896-902. [PMID: 19298601 DOI: 10.1111/j.1349-7006.2009.01126.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
10 Fernandez Larrosa PN, Alvarado CV, Rubio MF, Ruiz Grecco M, Micenmacher S, Martinez-Noel GA, Panelo L, Costas MA. Nuclear receptor coactivator RAC3 inhibits autophagy. Cancer Sci 2012;103:2064-71. [PMID: 22957814 DOI: 10.1111/cas.12019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
11 He LR, Zhao HY, Li BK, Liu YH, Liu MZ, Guan XY, Bian XW, Zeng YX, Xie D. Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int J Cancer. 2011;129:143-150. [PMID: 20830705 DOI: 10.1002/ijc.25669] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
12 Wei J, Cheang T, Tang B, Xia H, Xing Z, Chen Z, Fang Y, Chen W, Xu A, Wang S, Luo J. The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA. Biomaterials 2013;34:1246-54. [DOI: 10.1016/j.biomaterials.2012.09.068] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
13 Tong ZT, Wei JH, Zhang JX, Liang CZ, Liao B, Lu J, Fan S, Chen ZH, Zhang F, Ma HH, Qian WC, Kong LL, Fang Y, Chen W, Xie D, Luo JH. AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1. Br J Cancer 2013;108:1470-9. [PMID: 23511556 DOI: 10.1038/bjc.2013.81] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
14 Kim JH, Yu S, Chen JD, Kong AN. The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains. Oncogene 2013;32:514-27. [PMID: 22370642 DOI: 10.1038/onc.2012.59] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
15 Li S, Zhang H, Yu Y, Liu M, Guo D, Zhang X, Zhang J. Imbalanced expression pattern of steroid receptor coactivator-1 and -3 in liver cancer compared with normal liver: An immunohistochemical study with tissue microarray. Oncol Lett 2018;16:6339-48. [PMID: 30405769 DOI: 10.3892/ol.2018.9443] [Reference Citation Analysis]
16 Myllykangas S, Böhling T, Knuutila S. Specificity, selection and significance of gene amplifications in cancer. Semin Cancer Biol 2007;17:42-55. [PMID: 17161620 DOI: 10.1016/j.semcancer.2006.10.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
17 He LR, Liu MZ, Li BK, Jia WH, Zhang Y, Liao YJ, Chen YC, Zhang LJ, Guan XY, Zeng YX, Kung HF, Xie D. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Int J Cancer 2010;127:138-47. [PMID: 19904743 DOI: 10.1002/ijc.25031] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
18 Al-Otaiby M, Tassi E, Schmidt MO, Chien CD, Baker T, Salas AG, Xu J, Furlong M, Schlegel R, Riegel AT, Wellstein A. Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. Am J Pathol 2012;180:1474-84. [PMID: 22342158 DOI: 10.1016/j.ajpath.2011.12.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
19 Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.Signal Transduct Target Ther. 2019;4:62. [PMID: 31871779 DOI: 10.1038/s41392-019-0095-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 159] [Article Influence: 58.0] [Reference Citation Analysis]
20 Xu F, Xie D, Wen J, Wu H, Liu Y, Bi J, Lv Z, Zeng Y, Guan X. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas. Cancer Letters 2007;245:69-74. [DOI: 10.1016/j.canlet.2005.12.030] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
21 Alkner S, Bendahl P, Grabau D, Lövgren K, Stål O, Rydén L, Fernö M. AIB1 is a predictive factor for tamoxifen response in premenopausal women. Annals of Oncology 2010;21:238-44. [DOI: 10.1093/annonc/mdp293] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
22 Ferragud J, Avivar-Valderas A, Pla A, De Las Rivas J, Font de Mora J. Transcriptional repression of the tumor suppressor DRO1 by AIB1. FEBS Lett 2011;585:3041-6. [PMID: 21871888 DOI: 10.1016/j.febslet.2011.08.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
23 Luo J, Xie D, Liu M, Chen W, Liu Y, Wu G, Kung H, Zeng Y, Guan X. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Int J Cancer 2008;122:2554-61. [DOI: 10.1002/ijc.23399] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
24 Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, Tong Z, Li M, Majaz S, Liu Y. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene. 2015;34:3935-3945. [PMID: 25263446 DOI: 10.1038/onc.2014.324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
25 Li L, Deng CX, Chen Q. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer. Int J Mol Sci 2021;22:4760. [PMID: 33946224 DOI: 10.3390/ijms22094760] [Reference Citation Analysis]
26 Oh AS, Lahusen JT, Chien CD, Fereshteh MP, Zhang X, Dakshanamurthy S, Xu J, Kagan BL, Wellstein A, Riegel AT. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Mol Cell Biol 2008;28:6580-93. [PMID: 18765637 DOI: 10.1128/MCB.00118-08] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
27 Xu J, Wu RC, O’Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009;9:615-630. [PMID: 19701241 DOI: 10.1038/nrc2695] [Cited by in Crossref: 328] [Cited by in F6Publishing: 327] [Article Influence: 25.2] [Reference Citation Analysis]
28 He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. Cancer Sci. 2009;100:1591-1596. [PMID: 19552757 DOI: 10.1111/j.1349-7006.2009.01224.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
29 García-Barrado MJ, Blanco EJ, Iglesias-Osma MC, Carretero-Hernández M, Catalano-Iniesta L, Sanchez-Robledo V, Carretero M, Herrero JJ, Carrero S, Carretero J. Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas. Int J Mol Sci 2017;18:E2299. [PMID: 29104246 DOI: 10.3390/ijms18112299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Yan J, Erdem H, Li R, Cai Y, Ayala G, Ittmann M, Yu-Lee LY, Tsai SY, Tsai MJ. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 2008;68:5460-8. [PMID: 18593949 DOI: 10.1158/0008-5472.CAN-08-0955] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
31 He L, Zhao H, Li B, Zhang L, Liu M, Kung H, Guan X, Bian X, Zeng Y, Xie D. Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients. Annals of Oncology 2010;21:1675-81. [DOI: 10.1093/annonc/mdp592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
32 Yuan GJ, Chen X, Lu J, Feng ZH, Chen SL, Chen RX, Wei WS, Zhou FJ, Xie D. Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway. Cancer Sci 2017;108:2166-75. [PMID: 28837252 DOI: 10.1111/cas.13383] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
33 Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, Wang J, Qi R, Matzuk AJ, Song X, Madoux F, Hodder P, Chase P, Griffin PR, Zhou S, Liao L, Xu J, O'Malley BW. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res 2014;74:1506-17. [PMID: 24390736 DOI: 10.1158/0008-5472.CAN-13-2939] [Cited by in Crossref: 111] [Cited by in F6Publishing: 71] [Article Influence: 13.9] [Reference Citation Analysis]
34 Chen L, Wang C, Zhang X, Gao K, Liu R, Shi B, Hou P. AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients. J Cancer 2016;7:2052-60. [PMID: 27877220 DOI: 10.7150/jca.16069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zou JX, Zhong Z, Shi XB, Tepper CG, deVere White RW, Kung HJ, Chen H. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Prostate 2006;66:1474-86. [PMID: 16921507 DOI: 10.1002/pros.20477] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
36 Hsia EY, Zou JX, Chen HW. The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer. Prog Mol Biol Transl Sci 2009;87:261-98. [PMID: 20374707 DOI: 10.1016/S1877-1173(09)87008-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Habermann JK, Brucker CA, Freitag-Wolf S, Heselmeyer-Haddad K, Krüger S, Barenboim L, Downing T, Bruch HP, Auer G, Roblick UJ, Ried T. Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma. Mod Pathol 2011;24:542-55. [PMID: 21102417 DOI: 10.1038/modpathol.2010.217] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
38 Carretero J, Blanco EJ, Carretero M, Carretero-Hernández M, García-Barrado MJ, Iglesias-Osma MC, Burks DJ, Font de Mora J. The expression of AIB1 correlates with cellular proliferation in human prolactinomas. Ann Anat 2013;195:253-9. [PMID: 23433587 DOI: 10.1016/j.aanat.2013.01.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
39 Johnson AB, O'Malley BW. Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol Cell Endocrinol 2012;348:430-9. [PMID: 21664237 DOI: 10.1016/j.mce.2011.04.021] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 9.0] [Reference Citation Analysis]
40 Kumar R. Role of conformational dynamics and flexibilities in the steroid receptor-coregulator protein complex formation. Gen Comp Endocrinol 2021;309:113780. [PMID: 33882296 DOI: 10.1016/j.ygcen.2021.113780] [Reference Citation Analysis]
41 Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF, Guan XY. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol. 2008;39:80-86. [PMID: 17949776 DOI: 10.1016/j.humpath.2007.05.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
42 Yan J, Tsai SY, Tsai MJ. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin. 2006;27:387-394. [PMID: 16539836 DOI: 10.1111/j.1745-7254.2006.00315.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 3.7] [Reference Citation Analysis]
43 Wang L, Yu Y, Chow DC, Yan F, Hsu CC, Stossi F, Mancini MA, Palzkill T, Liao L, Zhou S, Xu J, Lonard DM, O'Malley BW. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell 2015;28:240-52. [PMID: 26267537 DOI: 10.1016/j.ccell.2015.07.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
44 Shi J, Liu W, Sui F, Lu R, He Q, Yang Q, Lv H, Shi B, Hou P. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer. Oncotarget 2015;6:14344-59. [PMID: 25970779 DOI: 10.18632/oncotarget.3852] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
45 Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, O'Malley BW. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol Endocrinol 2011;25:2041-53. [PMID: 22053001 DOI: 10.1210/me.2011-1222] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
46 Tien JC, Xu J. Steroid receptor coactivator-3 as a potential molecular target for cancer therapy. Expert Opin Ther Targets 2012;16:1085-96. [PMID: 22924430 DOI: 10.1517/14728222.2012.718330] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
47 An Y, Wu J, Yang B, Zhu Z, Gao M, Yu C, Yang CJ. Selection and Application of DNA Aptamer Against Oncogene Amplified in Breast Cancer 1. J Mol Evol 2015;81:179-85. [PMID: 26458993 DOI: 10.1007/s00239-015-9703-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Nikolai BC, Lanz RB, York B, Dasgupta S, Mitsiades N, Creighton CJ, Tsimelzon A, Hilsenbeck SG, Lonard DM, Smith CL, O'Malley BW. HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Res 2016;76:1463-75. [PMID: 26833126 DOI: 10.1158/0008-5472.CAN-15-2383] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
49 Huang Y, Cen J, Wei J, Chen Z, Fang Y, Feng Z, Lu J, Liang Y, Luo J, Mo C, Chen W. Impact of AIB1 expression on the prognosis of upper tract urothelial carcinoma after radical nephroureterectomy. Cancer Biomark 2019;25:151-60. [PMID: 31045512 DOI: 10.3233/CBM-182020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
50 Li XD, Chen SL, Dong P, Chen JW, Wang FW, Guo SJ, Jiang LJ, Zhou FJ, Xie D, Liu ZW. Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. Sci Rep 2016;6:20894. [PMID: 26869491 DOI: 10.1038/srep20894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
51 He L, Deng H, Liu S, Chen J, Li B, Wang C, Wang X, Jiang Y, Ma N, Liu M, Xie D. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4. Cancer Commun (Lond) 2018;38:53. [PMID: 30103827 DOI: 10.1186/s40880-018-0320-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Lira MC, Rosa FD, Panelo LC, Costas MA, Rubio MF. Role of RAC3 coactivator in the adipocyte differentiation. Cell Death Discov 2018;4:20. [PMID: 30062065 DOI: 10.1038/s41420-018-0085-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R. Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol 2017; 23(25): 4480-4490 [PMID: 28740336 DOI: 10.3748/wjg.v23.i25.4480] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
54 O’Malley BW, Kumar R. Nuclear receptor coregulators in cancer biology. Cancer Res. 2009;69:8217-8222. [PMID: 19843848 DOI: 10.1158/0008-5472.can-09-2223] [Cited by in Crossref: 85] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
55 Rubio MF, Lira MC, Rosa FD, Sambresqui AD, Salazar Güemes MC, Costas MA. RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition. Cancer Cell Int 2017;17:111. [PMID: 29209153 DOI: 10.1186/s12935-017-0483-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
56 Gojis O, Rudraraju B, Alifrangis C, Krell J, Libalova P, Palmieri C. The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease. Eur J Surg Oncol 2010;36:224-9. [PMID: 19716257 DOI: 10.1016/j.ejso.2009.08.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
57 Theodosi A, Glotsos D, Kostopoulos S, Kalatzis I, Tzelepi V, Ravazoula P, Asvestas P, Cavouras D, Sakellaropoulos G. Correlating Changes in the Epithelial Gland Tissue With Advancing Colorectal Cancer Histologic Grade, Using IHC Stained for AIB1 Expression Biopsy Material. Applied Immunohistochemistry & Molecular Morphology 2019;27:749-57. [DOI: 10.1097/pai.0000000000000691] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Harigopal M, Heymann J, Ghosh S, Anagnostou V, Camp RL, Rimm DL. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Res Treat 2009;115:77-85. [DOI: 10.1007/s10549-008-0063-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
59 Zhao Z, Zhou S, Li W, Zhong F, Zhang H, Sheng L, Li Y, Xu M, Xu J, Zhan L, Li B, Wang F, Xie D, Tong Z. AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma. J Cancer 2019;10:5212-22. [PMID: 31602272 DOI: 10.7150/jca.31697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Ma G, Ren Y, Wang K, He J. SRC-3 has a role in cancer other than as a nuclear receptor coactivator. Int J Biol Sci 2011;7:664-72. [PMID: 21647249 DOI: 10.7150/ijbs.7.664] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
61 Li Z, Fang ZY, Ding Y, Yao WT, Yang Y, Zhu ZQ, Wang W, Zhang QX. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population. World J Gastroenterol 2012; 18(8): 855-860 [PMID: 22371647 DOI: 10.3748/wjg.v18.i8.855] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
62 Liu MY, Guo HP, Hong CQ, Peng HW, Yang XH, Zhang H. Up-regulation of nuclear receptor coactivator amplified in breast cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis. Clin Transl Oncol 2013;15:947-52. [PMID: 23606350 DOI: 10.1007/s12094-013-1029-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]